Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate in Preventing Bone Loss in Postmenopausal Women With Aromatase Inhibitor Therapy for Breast Cancer
NCT00859703Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Nov 2009
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risedronate in osteopenia, sponsored by Hospices Civils de Lyon. Started Nov 2009; status: completed.
02
Drugs
risedronate
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00859703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859703.